Compare Innovative Industrial Properties Inc (IIPR) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innovative Industrial Properties Inc vs Natera Inc. Common Stock — how do they compare? Innovative Industrial Properties Inc trades at $51.47 (market cap $1.42B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 40.2× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays a 14.78% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Innovative Industrial Properties Inc for 87 Days and Natera Inc. Common Stock for 0 Days on average.
| IIPR | NTRA | |
|---|---|---|
Market Cap | $1.42B | $57.03B |
Volume | 575,289 | 1,131,157 |
Sector | Real Estate | Health |
52-Week High | $64.67 | $425.64 |
52-Week Low | $44.58 | $179.42 |
Typical Hold Time | 87 Days | 0 Days |
Enterprise Value | $1.95B | $56.18B |
Dividend Yield | 14.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $51.55, up 0.7% with a bearish technical signal but mixed fundamentals. The company reported declining revenue ($266M in 2025 vs. $309M in 2024) and net income ($118M vs. $162M), though Q2 2026 EPS beat expectations. Valuation metrics show a P/E of 11.64 and P/B of 0.82, suggesting potential undervaluation. Recent news highlights a $245 million mezzanine loan commitment and a $1.90 quarterly dividend.
Outlook: High dividend yield (13%+) and low P/B offer value, but tenant defaults and revenue declines pose risks. Analyst consensus is mixed (36% Buy, 55% Hold), with technicals bearish. Key catalysts include regulatory tailwinds and capital recycling, while risks involve sector volatility and dividend sustainability.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
